CN103142770B - Compound houttuynia cordata lotion and preparation method thereof - Google Patents

Compound houttuynia cordata lotion and preparation method thereof Download PDF

Info

Publication number
CN103142770B
CN103142770B CN201310078905.6A CN201310078905A CN103142770B CN 103142770 B CN103142770 B CN 103142770B CN 201310078905 A CN201310078905 A CN 201310078905A CN 103142770 B CN103142770 B CN 103142770B
Authority
CN
China
Prior art keywords
parts
lotion
herba
radix
houttuynia cordata
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310078905.6A
Other languages
Chinese (zh)
Other versions
CN103142770A (en
Inventor
张伟
周亚军
殷润婷
姚文娟
许晓乐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nantong University
Original Assignee
Nantong University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nantong University filed Critical Nantong University
Priority to CN201310078905.6A priority Critical patent/CN103142770B/en
Publication of CN103142770A publication Critical patent/CN103142770A/en
Application granted granted Critical
Publication of CN103142770B publication Critical patent/CN103142770B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses compound houttuynia cordata lotion. The lotion consists of the following components in parts by weight: 120 parts of houttuynia cordata, 80 parts of corydalis tuber, 80 parts of mirabilite, 80 parts of Chinese rhubarb, 60 parts of golden cypress, 60 parts of dandelion, 40 parts of radix sophorae flavescentis, 40 parts of Chinese violet, and 3.0 part of sodium benzoate. The compound houttuynia cordata lotion is reasonable in prescription and has a good effect.

Description

Compound houttuynin lotion and preparation method thereof
Technical field
The present invention relates to a kind of external anus edge lotion.
Background technology
" ten people's nine hemorrhoid ", anorectal disease is commonly encountered diseases, frequently-occurring disease, and anus edge edema, hyperemia, protuberance or swelling pain are the postoperative common complications of anorectal, incidence rate, up to 50%, has not only increased the weight of incision pain, also affects the healing of otch simultaneously.Existing external anus edge lotion, preparation is complicated, and curative effect is undesirable.
Summary of the invention
The object of the present invention is to provide a kind of formula reasonable, effective compound houttuynin lotion and preparation method thereof.
Technical solution of the present invention is:
A compound houttuynin lotion, is characterized in that: the medicine material by following weight portion is made:
120 parts of Herba Houttuyniae; 80 parts of Rhizoma Corydalis; 80 parts of Mirabilitums; 80 parts of Radix Et Rhizoma Rhei; 60 parts of Cortex Phellodendris, 60 parts of Herba Taraxacis, 40 parts of Radix Sophorae Flavescentiss; 40 parts of Herba Violaes; 3.0 parts of sodium benzoate.
A kind of preparation method of compound houttuynin lotion, it is characterized in that: Herba Houttuyniae, Rhizoma Corydalis, Mirabilitum, Radix Et Rhizoma Rhei, Cortex Phellodendri, Herba Taraxaci, Radix Sophorae Flavescentis, Herba Violae eight taste medicines are soaked 4 hours, solid-liquid ratio 1:15, g/ml, decoct 2 times, each 1 hour, merge extractive liquid,, filter after staticly settling 24 hours, discard filtering residue; Filtrate is concentrated, adds sodium benzoate to stir, filter, and adding distil water, subpackage, sterilization, obtains.
Compound houttuynin lotion has the effect of heat-clearing and toxic substances removing, regulating QI to relieve pain, promoting blood circulation and detumescence, dampness removing to stop itchin, washout anus anus edge sufferer part or demibain treatment, and through sick institute, curative effect tool is good.
Modern experimental pharmacology research shows: compound houttuynin lotion has antiinflammatory, detumescence, itching-relieving action.
1, compound houttuynin lotion antiinflammatory action
48 of CI R mices, are divided into 4 groups at random, 12 every group.Matched group (distilled water 2.5ml/kg); The basic, normal, high dosage group (5% of compound houttuynin lotion, 10%, 20% (V/V) 2.5ml/kg), each is organized after Mice Auricle coating 1h, with wet cotton balls, cleaned, give respectively the left ear of mice with 0.05ml/ caused by dimethylbenzene xylene inflammation, ear compares, and puts to death animal after 5min, with card punch (internal diameter 5.8mm), its ears are cut with position homalographic, weigh respectively, the difference of left and right auricle weight of take is its swelling degree, calculates and respectively organizes swelling and inhibitory rate of intumesce (%).Experimental studies results shows: compound houttuynin lotion has the effect of obvious inhibition Mice Auricle inflammatory swelling, its action intensity and dosage positive correlation.The results are shown in Table 1
The impact of table 1. compound houttuynin lotion xylol induced mice auricle inflammatory swelling
n=12)
Note: with Normal group comparison, * P < 0.05, * * P < 0.01
2, compound houttuynin lotion detumescence effect
40 of S D rats, are divided into 4 groups at random, 10 every group.Matched group (distilled water 1ml/kg); The basic, normal, high dosage group of compound houttuynin lotion (5%, 10%, 20% (V/V) 1ml/kg).Test the volumetric method mensuration that moves ahead and respectively organize the left back sufficient normal volume of rat (ml), then coating, only causes inflammation in the left back sufficient plantar subcutaneous injection 100% fresh albumen 0.05ml/ of each group rat after 1h, repaste medicine 1 time simultaneously, measure and cause scorching rear 1,2, the left back sufficient volume of 4,6h.The difference that the rat of take causes the sufficient volume in scorching front and back is swelling, calculates swelling and the inhibitory rate of intumesce of respectively organizing different time, respectively organizes the difference of swelling.Experimental studies results shows: compound houttuynin lotion has effect, inhibitory rate of intumesce and the dosage positive correlation of remarkable inhibition rat Ovum Gallus domesticus album pedal swelling.The results are shown in Table 2
Table 2, compound houttuynin lotion on the impact of rat Ovum Gallus domesticus album pedal swelling ( n=10)
Note: △ is histamine phosphate total amount, with matched group comparison, and with Normal group comparison, * P < 0.05, in * * P < 0.01 table, insertion of brackets data are inhibitory rate of intumesce
3, compound houttuynin lotion itching-relieving action
40 of Cavia porcelluss, are divided into 4 groups at random, 10 every group.Matched group (distilled water 1ml/kg); The basic, normal, high dosage group of compound houttuynin lotion (5%, 10%, 20% (V/V), 1ml/kg).List of references, 1d before experiment, to each group right back instep depilation of Cavia porcellus (about 1cm2), coating 1 time, test and abraded right back instep depilation place skin the same day, part repastes medicine 1 time, after last coating, 10min only starts to drip at wound surface place 0.01% histamine phosphate 0.05ml/, then every 3min, press 0.01%, 0.02%, 0.03% ... progressive concentration is only 0.05ml/ at every turn, until occur that the histamine phosphate total amount that Cavia porcellus gives while later licking metapedes is its itch-threshold, record is also respectively organized Cavia porcellus itch-threshold.Experimental studies results shows: compound houttuynin lotion significantly suppresses Cavia porcellus histamine phosphate itch-threshold, its itching-relieving action and dosage positive correlation.The results are shown in Table 3.
The impact of table 3, compound houttuynin lotion Dui Dui Cavia porcellus histamine phosphate itch-threshold ( n=10)
Note: △ is histamine phosphate total amount, with matched group comparison, and with Normal group comparison, * P < 0.05, * * P < 0.01.
Below in conjunction with embodiment, the invention will be further described.
The specific embodiment
Herba Houttuyniae 120g, Rhizoma Corydalis 80g, Mirabilitum 80g, Radix Et Rhizoma Rhei 80g, Cortex Phellodendri 60g, Herba Taraxaci 60g, Radix Sophorae Flavescentis 40g, Herba Violae 40g, eight taste medicines are soaked to (solid-liquid ratio 1:15, g/ml) 4 hours, decoct 2 times, each 1 hour, merge extractive liquid,, filter after staticly settling 24 hours, discard filtering residue.Filtrate is concentrated into 900-950ml, adds sodium benzoate 3.0g to stir, and filters, and adding distil water is to 1000ml, and subpackage, sterilizes, and obtains.
Quality standard:
Specification: 200ml/ bottle
Character: this product is light brown liquid, has a small amount of precipitation.
Check: relative density: should be not less than 1.02; PH value: 7.0-7.5.
Differentiate: get this product 5ml in test tube, drip sulfurous acid test solution, displaing amaranth.
Consumption usage: every day 2 times, anus edge washout (1:1 dilution); Demibain (each 50ml adds appropriate warm water).
Storage: the airtight storage in shady and cool place.
Effect duration: six months.

Claims (2)

1. a compound houttuynin lotion, is characterized in that: the medicine material by following weight portion is made:
120 parts of Herba Houttuyniae; 80 parts of Rhizoma Corydalis; 80 parts of Mirabilitums; 80 parts of Radix Et Rhizoma Rhei; 60 parts of Cortex Phellodendris, 60 parts of Herba Taraxacis, 40 parts of Radix Sophorae Flavescentiss; 40 parts of Herba Violaes; 3.0 parts of sodium benzoate.
2. the preparation method of a compound houttuynin lotion claimed in claim 1, it is characterized in that: Herba Houttuyniae, Rhizoma Corydalis, Mirabilitum, Radix Et Rhizoma Rhei, Cortex Phellodendri, Herba Taraxaci, Radix Sophorae Flavescentis, Herba Violae eight taste medicines are soaked 4 hours, solid-liquid ratio 1:15, g/ml, decoct 2 times, each 1 hour, merge extractive liquid,, filter after staticly settling 24 hours, discard filtering residue; Filtrate is concentrated, adds sodium benzoate to stir, filter, and adding distil water, subpackage, sterilization, obtains.
CN201310078905.6A 2013-03-13 2013-03-13 Compound houttuynia cordata lotion and preparation method thereof Expired - Fee Related CN103142770B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310078905.6A CN103142770B (en) 2013-03-13 2013-03-13 Compound houttuynia cordata lotion and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310078905.6A CN103142770B (en) 2013-03-13 2013-03-13 Compound houttuynia cordata lotion and preparation method thereof

Publications (2)

Publication Number Publication Date
CN103142770A CN103142770A (en) 2013-06-12
CN103142770B true CN103142770B (en) 2014-08-27

Family

ID=48541279

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310078905.6A Expired - Fee Related CN103142770B (en) 2013-03-13 2013-03-13 Compound houttuynia cordata lotion and preparation method thereof

Country Status (1)

Country Link
CN (1) CN103142770B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1097604A (en) * 1993-07-21 1995-01-25 黄勇 Fumigating and washing hemorrhoid curing powder and preparation method thereof
CN102233085A (en) * 2010-10-01 2011-11-09 刘叙光 External application drug for treating skin diseases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1097604A (en) * 1993-07-21 1995-01-25 黄勇 Fumigating and washing hemorrhoid curing powder and preparation method thereof
CN102233085A (en) * 2010-10-01 2011-11-09 刘叙光 External application drug for treating skin diseases

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
平川洗剂配合手术减压治疗肛肠术后肛缘水肿;陈冰璞等;《山东医药》;20091231;第49卷(第04期);第38页 *
方克勤.痔瘘熏洗方坐浴治疗肛门疾患临床观察.《新疆中医药》.2000,第18卷(第03期),
痔瘘熏洗剂在肛肠病术后中的应用;黄继承;《中国中医药信息杂志》;20090131;第16卷(第01期);第73-74页 *
痔瘘熏洗方坐浴治疗肛门疾患临床观察;方克勤;《新疆中医药》;20001231;第18卷(第03期);第23-24页 *
谢红等.鱼腥草注射剂治疗头皮银屑病疗效观察.《现代医药卫生》.2009,第25卷(第19期),
陈冰璞等.平川洗剂配合手术减压治疗肛肠术后肛缘水肿.《山东医药》.2009,第49卷(第04期),
鱼腥草注射剂治疗头皮银屑病疗效观察;谢红等;《现代医药卫生》;20091231;第25卷(第19期);第2904-2905页 *
黄继承.痔瘘熏洗剂在肛肠病术后中的应用.《中国中医药信息杂志》.2009,第16卷(第01期),

Also Published As

Publication number Publication date
CN103142770A (en) 2013-06-12

Similar Documents

Publication Publication Date Title
CN104474076A (en) Traditional Chinese medicine composition for treating eczema
CN103623071B (en) A kind of Powerful insect repellent for veterinary use and preparation method thereof
CN104288634B (en) It is a kind of to treat Chinese medicine of pruritus ani and preparation method thereof
CN102100720B (en) Ainsliaea fragrans champ caffeoylquinic acid extracts and preparation and application thereof
CN102380015B (en) Medicinal composition for treating rheumatoid arthritis and preparation method and application thereof
CN103751663A (en) Traditional Chinese medicine externally applied preparation for treating perianal eczema and preparation method thereof
CN102614287A (en) Film-spraying agent for treating acute soft tissue injuries
CN104013712A (en) Traditional Chinese medicine composition for treating pediatric eczematous dermatitis as well as preparation method and use thereof
CN106176784B (en) It is a kind of for the pharmaceutical composition of dermatitis, application, preparation and preparation method thereof
WO2008061447A1 (en) A medicine for treating eczema and process of ointment thereof
CN103623046A (en) Composite playing auxiliary protection role in chemical and alcoholic liver injury, preparation method of composite and application of composite in health-care food
JP2005530697A (en) The use of Jacobic whole coumarins in the preparation of a medicament for the treatment of psoriasis
CN102670977B (en) Chinese medicinal composition for treating arthralgia, preparation method and applications of Chinese medicinal composition
CN103142770B (en) Compound houttuynia cordata lotion and preparation method thereof
CN104162058A (en) Traditional Chinese medicine compound preparation for treating gout and preparation method thereof
CN102988844A (en) Gynaecological gel and extraction method thereof
CN103536850B (en) A kind of Chinese medicine of internal and external application treatment verruca plana
CN102697932B (en) Medicinal composition for treating skin itch and quality detection method
CN114209756B (en) Anti-inflammatory and antipruritic traditional Chinese medicine composition and preparation method and application thereof
CN102048850A (en) Traditional Chinese medicine external preparation for curing infantile eczema and preparing method thereof
CN1682813A (en) Chinese medicine solution agent for treating damp-heat disease and its preparing method
CN103271969A (en) Traditional Chinese medicine composition for treating traumatic injury and quality control method thereof
CN102961499A (en) Traditional Chinese medicine nigrum fruit product and preparation method and application thereof
CN105434915A (en) Pharmaceutical composition for treating urolithiasis for dogs and cats and preparation method of pharmaceutical composition
CN109331153A (en) A kind of Medical-use cold compress gel and preparation method thereof for treating children&#39;s dermatitis and eczema

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140827

Termination date: 20150313

EXPY Termination of patent right or utility model